PGP and neoplasm: Longer progression free survival has been observed in patients with none or very few MDR-1 P-gp positive tumour cells compared to patients with a larger proportion of MDR-1 Pgp positive tumour cells [16,17]; however higher MDR-1 expression has been associated with a better outcome also [18,19].